An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...

In order to plan and conduct pediatric clinical trials we need to address the unique ethical issues. Children require a higher standard of ethics, regulatory and developmental consideration. Since ...

From a trial design perspective, we’ve tried to make these trials as familiar to stakeholders – regulators, prescribers, payors – as possible. What’s remarkable here are the qualities of the drug that ...

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Educational ...

How can you design and execute early phase trials to get the results needed with limited resources and time? We need to balance what we can do and the resources we have with what needs to be done for ...

Cancer is not static. It evolves, mutates, adapts, and resists. That volatility makes clinical trials a critical component of cancer treatment. Yet despite advances resulting from these studies, only ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...

Stress has often been called the psychological problem of the 21 st century. Though stress can have some advantageous effects when it comes to productivity, it can also be significantly detrimental to ...

Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...

Dr. Hope Rugo and Dr. Vivek Subbiah discuss innovative trial designs to enable robust studies for smaller patient populations, as well as the promise of precision medicine, novel therapeutic ...